Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Getinge ( ($SE:GETI.B) ).
Getinge has announced that it will release its Q3 Report for 2025 on October 21, followed by a conference call hosted by its President & CEO and CFO. The call is open to fund managers, analysts, and media, allowing them to participate and ask questions, which underscores Getinge’s commitment to transparency and stakeholder engagement.
The most recent analyst rating on ($SE:GETI.B) stock is a Hold with a SEK218.00 price target. To see the full list of analyst forecasts on Getinge stock, see the SE:GETI.B Stock Forecast page.
More about Getinge
Getinge is a company dedicated to providing hospitals and life science institutions with products and solutions designed to improve clinical outcomes and optimize workflows. Their offerings include products for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing, and life science. Getinge employs about 12,000 people globally and sells its products in 135 countries.
Average Trading Volume: 516,180
Technical Sentiment Signal: Strong Buy
Current Market Cap: SEK58.12B
For a thorough assessment of GETI.B stock, go to TipRanks’ Stock Analysis page.